Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...
Snag is, Cheniere’s two export terminals are already advanced enough to generate several billion dollars in cash flow, much of which is already flowing in dividends to shareholders. Venture Global is ...
Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...
2don MSN
"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an ...
Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.
More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered ...
Leading fintech firm Pine Labs is gearing up to file its initial public offering (IPO) documents by mid-February. The company ...
A privately held company, Gecko Robotics develops AI-driven maintenance solutions, attracting industries like mining and ...
The energy company raised $1.75 billion by pricing 70 million shares at $25, the middle of its reduced $23 to $27 price range ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback